Screener
Penumbra PEN United States — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Penumbra in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Penumbra’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:45 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001321732-26-000019
FAQ
- What is Penumbra's united states — revenue?
- Penumbra (PEN) reported united states — revenue of $296.39M in Q1 2026.
- How has Penumbra's united states — revenue changed year-over-year?
- Penumbra's united states — revenue increased by 15.4% year-over-year, from $256.86M to $296.39M.
- What is the long-term trend for Penumbra's united states — revenue?
- Over 4 years (2021 to 2025), Penumbra's united states — revenue has grown at a 19.9% compound annual growth rate (CAGR), from $527.79M to $1.09B.
- What does united states — revenue mean?
- This metric represents the total gross revenue generated from sales of medical devices and related services within the United States geographic segment. It reflects the company's ability to capture market share and drive adoption of its neurovascular and peripheral vascular product portfolios among domestic healthcare providers. This figure is a primary indicator of the company's commercial success and growth trajectory in its largest market.
Ask your AI about Penumbra's united states — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude